Literature DB >> 35236980

A visual guide to restoring the guardian of the genome.

Michael Eisenstein.   

Abstract

Entities:  

Keywords:  Cancer; Medical research; Molecular biology

Mesh：

Year:  2022        PMID： 35236980     DOI： 10.1038/d41586-022-00566-w

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

Review 1.  Therapeutic targeting of p53: all mutants are equal, but some mutants are more equal than others.

Authors:  Kanaga Sabapathy; David P Lane
Journal:  Nat Rev Clin Oncol       Date:  2017-09-26       Impact factor: 66.675

Review 2.  The first 30 years of p53: growing ever more complex.

Authors:  Arnold J Levine; Moshe Oren
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

3.  Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study.

Authors:  Shunji Takahashi; Yutaka Fujiwara; Kenji Nakano; Toshio Shimizu; Junichi Tomomatsu; Takafumi Koyama; Mariko Ogura; Masaya Tachibana; Yasuyuki Kakurai; Tomonari Yamashita; Sakura Sakajiri; Noboru Yamamoto
Journal:  Cancer Sci       Date:  2021-05-02       Impact factor: 6.716

Review 4.  Structural and Drug Targeting Insights on Mutant p53.

Authors:  Ana Sara Gomes; Helena Ramos; Alberto Inga; Emília Sousa; Lucília Saraiva
Journal:  Cancers (Basel)       Date:  2021-07-03       Impact factor: 6.639

Review 5.  Census and evaluation of p53 target genes.

Authors:  M Fischer
Journal:  Oncogene       Date:  2017-03-13       Impact factor: 9.867
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.